ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells

Yoon Kyung Jo1, So Jung Park, Ji Hyun Shin

  • 1Institute for Innovative Cancer Research, Asan Medical Center, Seoul 138-736, Republic of Korea.

Insights

A selective matrix metalloproteinase-2 (MMP-2) inhibitor, ARP101, potently induces autophagy, a cellular self-digestion process. This autophagy induction by ARP101 is linked to significant cell death, highlighting a novel therapeutic avenue.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Autophagy is a fundamental cellular process for macromolecule and organelle turnover, crucial for cellular stress response.
  • While often protective, autophagy can be implicated in cell death pathways and acts as a tumor suppressor mechanism.
  • Identifying specific regulators of autophagy is key to understanding its diverse roles.

Purpose of the Study:

  • To identify novel chemical regulators that modulate autophagy.
  • To investigate the mechanism by which identified compounds induce autophagy.
  • To determine the role of autophagy in ARP101-induced cell death.

Main Methods:

  • Screening of chemical libraries (Lopac 1280, Prestwick) using a GFP-LC3 autophagy marker system.
  • Treatment of cells with ARP101 and assessment of autophagosome formation and LC3 conversion (LC3I to LC3II).
  • Utilizing ATG5(-/-) MEF cells to confirm autophagy-dependent effects and employing 3-methyladenine and zVAD to dissect cell death pathways.

Main Results:

  • ARP101 was identified as a potent inducer of autophagy, significantly increasing autophagosome formation and LC3II levels.
  • ARP101-induced autophagy was dependent on ATG5, confirming its role in the autophagic pathway.
  • Cell death induced by ARP101 was mediated by autophagy, as it was blocked by autophagy inhibitors but not by caspase inhibitors.

Conclusions:

  • ARP101, a selective MMP-2 inhibitor, is a potent inducer of autophagy.
  • The study demonstrates that ARP101-induced cell death is associated with and dependent on autophagy.
  • These findings suggest ARP101 as a potential therapeutic agent targeting pathways involving autophagy and cell death.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...